DFX Intelligence

Kevin Paul Starr

Role unknown· MA

As of 2026-09-12 · this person's identity; each section below carries its own date

Current roles: 0
Investments attributed: 1
Board seats: 1

Ask DFX about this View relationships Find contacts Investments Board seats

As of 2026-09-12 · this person's identity; each section below carries its own date

Nothing material in the last 365 days. Last change: 5 Nov 2009, Latest Afferent Pharmaceuticals Form D equity offering ($150K) on 5 Nov 2009.

Relationship network

2 connected entities1 observed investment recordinvestment records 2009

From the roles sources name this person in, the investments a source attributes to them, and the boards and funds Form D names them on.

Kevin Paul Starr

Reading the network

Organization
Company

›How strength and recency are read

Venture relationships are not scored. Each line names its claim: a round led or joined, a board seat or a filing that names the firm, a listing on a portfolio page (dated by when DFX saw it, never by when the investment was made), a disclosed LP commitment, or a co-investor pair counted from observed participations. Observed means a named source says so; Derived means DFX counted it from observed rows; Inferred means a match that may be wrong.

Darker lines were active in the last 24 months or are current; lighter lines are older or undated.

Ask DFX about this network

Which companies and boards is Kevin Paul Starr connected to?

How am I connected?

Name your firm, a company or a person, and DFX finds the published routes to Kevin Paul Starr: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.

See how you connect to Kevin Paul Starr

Includes 3 days of DFX Intelligence. Then $199/month unless canceled.

Drawing the relationship network…

Roles

0 current, 1 past

Third Rock Ventures, LLC. Manager/Member
Dec 1, 2014 to Mar 31, 2022 · “Listed on Schedule A of filing 2021-03-31 as MANAGER/MEMBER, absent from filing 2022-03-31”
Inference Form ADV

Investments attributed to this person

Company	Round	Investor	Attribution	Date	Source
Afferent Pharmaceuticals	Form D equity offering · $150,000	Third Rock Ventures, LLC.	strongly supported · board	Nov 5, 2009	Inference sec.gov

Board seats and vehicles

1 board, 0 vehicles

Afferent Pharmaceuticals board seat on a deal Nov 5, 2009 Inference

Timeline

4 dated entries: events, attributed deals, board seats and role changes

Mar 31, 2022
Kevin Paul Starr (Manager/Member) no longer on Schedule A of Third Rock Ventures, LLC.
Person left Inference Third Rock Ventures, LLC. Form ADV
Mar 31, 2022
Left Third Rock Ventures, LLC. as Manager/Member
Role ended Inference Third Rock Ventures, LLC. Form ADV
Dec 1, 2014
Joined Third Rock Ventures, LLC. as Manager/Member
Role began Inference Third Rock Ventures, LLC. Form ADV
Nov 5, 2009
Form D equity offering in Afferent Pharmaceuticals (Third Rock Ventures, LLC.)
Attributed investment Inference Afferent Pharmaceuticals Form D

Record history

1 dated event on the change ledger, latest event first

Person left
2022-03-31source on record

The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.